SOURCES SOUGHT
65 -- Safety Needles and Syringes
- Notice Date
- 6/12/2007
- Notice Type
- Sources Sought
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMC Portsmouth, 54 Lewis Minor St, Portsmouth, VA, 23708-2297, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- Reference-Number-TMAR-36
- Response Due
- 7/3/2007
- Archive Date
- 7/18/2007
- Description
- A. General Information The Tri-Service Mid-Atlantic Region, a military integrated delivery network, comprised of Army, Navy, Air Force, Marine Corps and Coast Guard medical commands and medical treatment facilities (MTFs) in the states of Virginia and North Carolina announces a Request for Regional Incentive Agreement Quotation (REFRIAQ) for the standardization of Safety Needles & Syringes. The major facilities in the area includes: 1st Medical Group, Langley AFB, VA; 43rd Medical Group, Pope AFB, NC; 4th Medical Group, Seymour Johnson AFB, NC; Womack Army Medical Center, FT Bragg, NC; McDonald Army Community Hospital, FT Eustis, VA; Kenner Army Health Clinic, FT Lee, VA; Naval Medical Center Portsmouth, Portsmouth, VA; Naval Hospital Camp Lejeune, Camp Lejeune, NC; Naval Hospital Cherry Point, Cherry Point MCAS, NC. The primary objective of this standardization initiative is to achieve a best value determination for Safety Needles & Syringes that represents the clinically preferred product from a source at the best possible price. It is also intended that standardized product be obtained through the DoD Prime Vendor Program. This procurement is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia, Directorate of Medical Materiel. To participate, your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendors for the program for their distribution of your products. This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendors to distribute their items. This is a supplement to the Prime Vendor Program and it is not a contract. For additional information regarding DSCP?s Prime vendor program please access our web site at https://dmmonline.dscp.dla.mil The Mid-Atlantic Tri-Service Regional Business Office (TRBO) will provide anticipated volume (quantity) based on historical usage/forecasted requirements. The agreement will be for a base period of two (2) years (24 months) from date of award with three (3) 12-month option periods. Anticipated award date is July 2007. The evaluation will be based on clinical, technical, and pricing factors. The award will be determined on a best value basis. Point of Contact is Greg Morrison, 757-953-5804 or gregory.morrison@med.navy.mil B. Products & Performance Required The Mid-Atlantic Region is seeking product line items in the category of Safety Needles & Syringes. The approximate annual purchase volume of $417,000 is based upon the historical usage of standardized Safety Needles & Syringes over a one year period. The overall evaluation will be based upon clinical, technical and pricing factors. The final award recommendation will be determined on a ?best value? basis. The Prime Vendor for the Mid-Atlantic Region is Owens & Minor. At the request of the Mid-Atlantic Region MTFs, vendors will provide on-site support and in-servicing, educational resources and tools for clinical use of the product, conversion information, prime vendor order numbers, MSDS information, and itemization of the brands, types and packaging information of the products offered by the vendor. C. Instructions to Offerors DAPA holders interested in participating in this standardization initiative, should email responses to gregory.morrison@med.navy.mil and provide: (1) Company name and address, (2) POC (Name and Phone Number, Fax Number, and E-mail address) (3) your company?s Distribution and Pricing Agreement (DAPA) number and (4) your company?s responses to the questions under paragraph D.2, Technical/Company Criteria below. Your email will include your agreement to provide the necessary technical criteria, ?no charge? samples for clinical evaluation, and submission of electronic best price offers that represent a discount from your company?s base uncommitted DAPA pricing. Failure to provide the information requested in the timeframes specified will result in your company being eliminated from further consideration. Note: Due to the potential for email to be lost in transmission from network security, etc., vendors are strongly encouraged to confirm with the Region that its initial submission, quote and literature actually arrived at the Region via email. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before the due date/time, should a problem occur with the first submission. Vendors are advised that submission of information, samples and participation in clinical trials, etc., is done at no cost to the Government For any subsequent mailing purposes, please use the following address: Gregory Morrison Tri-Service Regional Business Office Financial Operations Department, Bldg. 250 Naval Medical Center Portsmouth 620 John Paul Jones Circle Portsmouth, VA 23708 Email responses must be received no later than 4:00 P.M (EST), seven (7) calendar days from the closing of this FBO Notice. Failure to respond within this timeframe will result in your company being excluded from future participation in this standardization effort. Emails and correspondence may be sent to gregory.morrison@med.navy.mil D. Evaluation Criteria Vendors will be required to provide responses to the technical/company criteria below. A Clinical Product Team (CPT) will review the responses and determine acceptability. After review of the technical/company criteria, the Region will eliminate those vendors who fail to meet the criteria. Those companies who do meet the technical/company criteria will be invited to participate in the clinical/performance evaluation. For those companies meeting the criteria, the CPT will request samples from the product group to be clinically evaluated at select Military Treatment Facilities (MTFs). Vendors are required to provide samples (at no cost to the government) to the MTFs. Vendor samples must be provided no later than 4:00 P.M. (EST), two (2) weeks after the request is issued to the vendors. Vendors failing to provide by the deadline will be disqualified from further consideration in the standardization process. 1. The MTFs will evaluate the products provided with the clinical/performance criteria identified in this announcement using a zero to seven rating scale. Zero is equal to ?not acceptable? and seven is equal to ?highly acceptable?. The TPRB has set a 3.75 acceptability threshold for all products. Summary ratings for each vendor will be an average of their numerical scorings combined with an adjectival scale of ?highly acceptable?, ?acceptable?, ?minimally acceptable?, and ?not acceptable?. All clinical criteria are weighted equally. The scale descriptors are: 0 = ?not acceptable? and 7 = ?highly acceptable?. Clinical/performance results lower than 3.75 will result in disqualification from further consideration in the standardization process. 2. After the clinical/performance evaluation are completed and analyzed, all vendors in the clinical evaluation group who met the 3.75 threshold will be asked to submit their best pricing offer representing a discount from their DAPA pricing based on a minimum committed volume of 80% of the total requirements for MTFs in the Mid-Atlantic Region. Vendors that fail to offer pricing that is discounted from their DAPA pricing will be eliminated from further consideration. Vendor Product and Price Proposals will be in the Excel template provided by the government. The vendors will provide their completed Excel template by email to gregory.morrison@med.navy.mil. Pricing offers must be received by 4:00 P.M. (EST) two (2) weeks from the date the request is initiated by the TRBO. Failure to respond within this timeframe will result in your company being excluded from further participation/consideration. Clinical/performance factors will be weighted more heavily than price. Pricing will be evaluated based on best value to the government and will be based on a committed volume for a two-year period with possible one-year option periods (not to exceed 5 years). Technical/Company Criteria: The CPT will review the responses to the following technical criteria from each vendor and determine acceptability. Acceptability for the purpose of evaluation of the technical criteria means the responses to all questions in this section demonstrate that: 1) the vendor, who will be named the quoter, offering the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; 2) based on the quoter?s responses, the evaluators have reasonable confidence that the product line or products and/or services offered meet the medical standards of care of the community in which such products and/or services are applicable; 3) the quoter has a DAPA for the product line, products and/or services; and 4) the quoter has an agreement covering the distribution of their products with Owens and Minor, the Prime Vendor for the region. 1. Does your company manufacture/distribute sterile safety needles and syringes? 2. What is your DAPA Number? 3. Are your products available through the Prime Vendor, Owens & Minor? 4. Under what brand(s) does your company manufacture or distribute your products? 5. Under what standards are your products manufactured? 6. Are your products latex free? 7. What material are your syringes made of? 8. Do you use non-toxic, color fast dyes for labeling on your products? 9. Do your syringes come capped and sterile in a package that can be delivered to a sterile field? 10. Are your syringes incompatible with any fluids or medications? 11. What sizes are available for your syringes? 12. What tip styles are available for your syringes? 13. What material are your needles made of? 14. Does your company have safety needles that can be used with conventional syringes? 15. What gauges and lengths do your safety needles come in? 16. Do your safety needles and syringes come as one unit? 17. Is the safety feature an integral part of the safety needle and syringe? 18. Does the safety feature activate automatically or does it have to be activated by the user? 19. Does the safety feature require the user?s hands to remain behind the needle at all times? 20. After activation of the safety feature, does it remain activated during removal of the needle from the patient and after disposal? 21. What types of educational tools or materials do you have for this product line? 22. What kind of staff training does your company provide? 23. Does your company provide customer service 24/7? 24. Is there any history of backorders and/or recalls for this product group? If yes, please answer: a. Dates and duration b. Cause c. Resolution 25. Is you company willing to offer pricing discounts from your DAPA pricing in return for a volume product purchase commitment by regional participating commands Clinical/Performance Criteria: A Clinical Product Team (CPT) will evaluate the products based upon on the following evaluation criteria to determine acceptability 1. Ergonomically designed, comfortable to hold, lightweight, can be used in either hand. 2. Easy to use with minimal training required. 3. Activation of the safety device is easy. 4. Activation of the safety feature is obvious. 5. The safety device does not activate passively. 6. The needle and syringe cannot be reused once the safety feature is activated. 7. The fluid can be easily viewed in the barrel. 8. The labeling is easy to read. 9. The syringe plunger moves easily within the barrel. 10. The package is easy to open and allows for aseptic delivery to the sterile field. 11. The size and type of the device is easily identified from the packaging 12. Overall clinical satisfaction
- Place of Performance
- Address: Tricare Mid-Atlantic, Naval Medical Center, Portsmouth, VA
- Zip Code: 23708-2297
- Country: UNITED STATES
- Zip Code: 23708-2297
- Record
- SN01316824-W 20070614/070612221500 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |